Latest News and Blogs >

Oxford Biomedica collaborate on novel biocomputer system
BiologIC Technologies and Oxford Biomedica collaborate on novel biocomputer system for viral vector development
Oxford Biomedica and BiologIC Technologies enter into a development agreement
Biolog...
Read More
RNA vaccine manufacture
UK GOVERNMENT AWARDS £475,000 TO BIOLOGIC TECHNOLOGIES FOR THE DEVELOPMENT OF TECHNOLOGY FOR RNA VACCINE MANUFACTURE
£475,000 of UK Aid funding has been awarded to develop technology for rapid, acc...
Read MoreBiologIC Featured in New Electronics Magazine
We are delighted to have been featured in New Electronics magazine. The article describes how the proprietary technology in our biocomputer can enable a biorevolution in much the way that the integrat...
Read MoreWelcome to the Biocomputer
60% of all the physical inputs into the global economy could be produced using biology, according to McKinsey. Advances in genomics, synthetic biology, lab grown food, biofuels, DNA data and in person...
Read MoreIndustry 4.0
Watch this video to learn how Industry 4.0 will create $3.7 trillion in disruptive value by blurring the lines between the digital, the physical and the biological. BiologIC’s industry 4.0 platform in...
Read More
UK group says 3D printed automated control tech can cut mAb production costs
by Gareth Macdonald
Bioprocess International
Monday, August 23, 2021 7:56 am
Automation provides a path to cheaper, faster monoclonal antibody (mAb) production says the UK consortium, whi...
Read More
UK biomanufacturing team to spearhead development of advanced controls to accelerate drug and vaccine manufacturing
A UK-based consortium comprising of BiologIC Technologies, Biopharm Services, CPI, Pall Corporation, and SCIEX has announced the launch of a project aiming to develop automated manufacturing controls ...
Read More
BiologIC Technologies Awarded £435,000 Biomedical Catalyst grant for continuous bioprocessing
BiologIC Technologies has been awarded a Biomedical Catalyst grant of £435,000 from Innovate UK, as part of a UK-based consortium, to develop an Advanced Fluidic Control System for continuous bioproce...
Read More
BioMet team at the National Physical Laboratory (NPL) identifies critical parameters for the performance of 3D bio-processors
BiologIC Technologies is a commercially focused technology business developing breakthrough digital hardware architectures integrating fluidics, electronics, thermals, optics, and pneumatics. The arc...
Read More
BiologIC featured in Stratasys case study
As a pioneer in the "second wave of additive", we were delighted to be asked by Stratasys to feature in a dedicated case study. Please read all about it here:
Stratasys Polyjet case study...
Read More
Mastering Free Complexity
The Fourth Industrial Revolution has extensive dependency on additive manufacturing. BiologIC is pioneering the “second wave of additive”.
The first wave has mainly used 3D printing for prototyping d...
Read More
BiologIC Technologies helps implement high-throughput heat inactivation of patient samples at Cambridge Lighthouse Laboratory
CAMBRIDGE, UK 29 April 2021: BiologIC Technologies, a pioneer in Industry 4.0 technologies for the bio-revolution, has collaborated with AstraZeneca and Electrolux Professional to implement a high-th...
Read More
Cambridge 105: Industry 4.0 technologies
BiologIC`s Richard Vellacott talks to Cambridge 105's Ian Daborn about synthetic biology and how BiologIC will unlock its exciting potential using Industry 4.0 technologies.
To hear the full intervie...
Read More
The Second Wave of Additive
Stratasys hosts BiologIC’s Richard Vellacott to discuss industry 4.0 and the 2nd wave of additive manufacturing.
Hosted by Zehavit Reisin VP,EMEA and NASA Head of solutions and material business.
To...
Read More
The Future Microsoft for the Biorevolution
EXECUTIVE INTERVIEW – BiologIC Technologies: The Future Microsoft for the Biorevolution
The following article appeared in Drug Development and Delivery
BiologIC Technologies is a world leader in ...
Read More3D printing as an enabler of future architectures
BiologIC’s pioneering digital architectures for radically different automation in synthetic biology deploy the latest developments in 3D printing technology.
...
Read More
Completing the Holy Trinity in the Digitisation of Biology
Biology has incredible potential to benefit society, but the scale up phase is severely constrained. To unlock this disruptive value, we need to complete the Holy Trinity of digital software, wetware...
Read MoreSolving the tyranny of numbers in life sciences
Life sciences is stuck in a rut. Whilst we are making incredible strides in discovering new bioproducts enabled by our ability to “read DNA” and “write DNA”, we are only just beginning to “apply DNA”...
Read MoreUnlocking the next wave of synthetic biology
Synthetic biology is the field where the twin disciplines of technology and biology meet. Since the sequencing of the first human genome in the early 2000s, the first wave of synbio, our ability to “...
Read More
OnDrugDelivery: BiologIC's view of the future for Drug Manufacturing
BiologIC is hugely excited about Advanced Therapies (ATs) and we see a new era of medicine enabled by these therapies.
One opportunity in this new era is the model of delivery of therapies to patien...
Read More